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INTRODUCTION: 
It is well recognised that critical illness contributes to development of muscle weakness (ICU-
AW) [1] with evidence that atrophy is caused by increased breakdown and decreased 
synthesis of muscle protein [2-5]. This may be secondary to inflammation, immobilisation, 
changes in endocrine stress responses, nutritional deficit and denervation, yet none of the 
above show direct correlation with ICU-AW [5].  
Skeletal muscle loss occurs early and rapidly during the first week of critical illness and is more 
severe among those with multi-organ failure compared with single organ failure [6]. For 
critically ill patients with Acute Respiratory Distress Syndrome (ARDS) muscle weakness is the 
single greatest determinant of functional outcome [6]; the weakness impeding rehabilitation 
and recovery due to prolonged inactivity, a catabolic state and reduced nutritional uptake [7]. 
Similarly, impaired diaphragm contractility has profound long-term sequelae resulting in   
prolonged periods of mechanical ventilation, delayed weaning and potential ongoing 
respiratory compromise [8]. 
 
Low tidal volume (LTV) ventilation is associated with a reduced risk for developing ventilator 
induced lung injury with or without ARDS [9].  Meta-analyses have demonstrated fewer 
pulmonary infections, less atelectasis and shorter length of stay with targeted lung volumes 
[10]. As such, LTV ventilation or ‘lung protective ventilation’ has become common place in 
critical care [11]. However, an accepted side-effect of LTV is ‘permissive’ hypercapnia.  
 
Little is known about the influence of hypercapnia on muscle wasting in humans but animal 
models have shown that severe acute acidosis can protect the contractility of the diaphragm 
[12]. A recent study using a healthy animal model demonstrated that moderate prolonged 
Page 3 of 21 
 
hypercapnia (defined as PaCO2 between 7.3kPa and 9.3kPa for 72 hours) protected against 
ventilator induced diaphragmatic dysfunction (VIDD) [12], this is possibly as a consequence 
of an anti-inflammatory effect mediated by preventing oxidative stress and NF-kappa B 
activation [13, 14, 15]. It remains unknown if this effect occurs in humans, and whether 
hypercapnia could prevent both diaphragmatic and peripheral skeletal muscle wasting in 
critically ill patients.  
 
The aim of this pilot study was therefore to investigate the effect of hypercapnia on changes 
in respiratory and peripheral skeletal muscle in critically ill patients receiving mechanical 
ventilation. 
 
METHODS 
Study Design 
A prospective observational pilot study to measure change in respiratory muscle (diaphragm) 
thickness and peripheral skeletal muscle (quadriceps rectus femoris cross-sectional area 
(RFCSA)) in three non-matched groups of invasively mechanically ventilated patients with 
differing levels of arterial carbon dioxide.  
Ethical approval 
Ethical approval was obtained from Wales Research Ethics Committee – REC3 (14/WA/0054).  
Written informed consent was provided directly from patients or their personal consultee 
(with retrospective patient consent obtained once capacity restored). 
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Participants 
Adult (≥ 18 years of age) patients admitted to a 32-bedded tertiary referral critical care unit 
and receiving a mandatory mode of invasive mechanical ventilation, were eligible for the 
study.   
Two groups of patients were initially identified with a further retrospective grouping of 
patients during analysis. Group 1 consisted of patients admitted with acute brain injury (ABI). 
This group was included as patients with brain injury normally ventilated to a PaCO2 4.5 - 
5.0kPa and on similar medication to those admitted with severe respiratory failure (e.g. 
sedation, use of paralysing agents). The remaining included patients had no diagnosis of head 
injury. At the end of the study this group of non head injury patients were retrospectively 
categorised into ‘Normocapnic’ [Group 2] (PaCO2 4.6 – 5.9kPa) or ‘Hypercapnic’ [Group 3] 
(≥6kpa) groups according to average PaCO2 during the study period (calculated from daily 
blood gases).  
Exclusion criteria included expected deterioration leading to death within 24 hours, pre-
existing muscle or neuromuscular disease, or chronic respiratory disease. 
Sample Size 
No previous studies provided sufficient data for a sample size calculation to be carried out. A 
convenience sample of 30 was used to ensure 10 participants in each group. This was deemed 
feasible within the funding period of the study. 
Protocol 
Ultrasonographic measurements of RFCSA and diaphragm thickness were completed using a 
Sonosite X-Porte© ultrasound device (FujifilmTM) based on previously described techniques [5, 
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7, 16]. Subjects were positioned semi-supine with the legs rested in passive extension.  Use 
of excess ultrasound gel facilitated image quality, and the visual feedback was used to obtain 
the smallest cross-sectional area / diaphragm thickness in each image. Minimal compression 
was applied to avoid compression of the underlying muscle.    
Measurements of RFCSA and diaphragm thickness commenced within the first 24 hours of 
initiation of mechanical ventilation (classified as ‘baseline’), and were repeated on Days 3, 5, 
7, and 10 or until discontinuation of mechanical ventilation (whichever occurred first).  
For the diaphragm, a 13-6MHz rectangular transducer (L25xp, Sonosite S Series Ultrasound, 
Hitchin, UK) was placed in the right mid-auxiliary line between the 8th and 9th rib. Confirmation 
of imaging the diaphragm was made through direct visualisation of a contraction or passive 
stretching. All images were obtained at end-expiration. 
RFCSA was determined using a 5-2MHz curvilinear transducer (C60xp, Sonosite S Series 
Ultrasound, Hitchin, UK). Distance from the anterior superior iliac spine (ASIS) to the superior 
patellar border was measured and a point marked on the thigh, at two-thirds of this distance.  
The transducer was placed perpendicular to the long axis of the thigh on the superior aspect. 
Ultrasound images were analysed using Image J software (Image J, U.S. National Institutes of 
Health, Maryland USA, http://rsb.info.nih.gov/ij/). For both the diaphragm and RFCSA, three 
images were obtained at each time point.An average of three measurements (all within a 10% 
variance) was calculated from each image and then an overall average was then calculated 
for the three images captured at each time point to provide a single figure for diaphragm 
thickness and RFCSA. 
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Statistical analysis 
Demographic data was analysed using descriptive statistics. Inter-group baseline differences 
were analysed using either one-way anova with poc hoc bonferonni tests or Kruskall-Wallis 
for non-parametric data. 
Changes in diaphragm thickness and RFCSA were calculated by percentage change from 
baseline (within 24 hours of initiating mechanical ventilation) to each subsequent assessment 
point (Days 3, 5, 7 and 10). To assess the degree of change in muscle thickness / cross sectional 
area, all data were assessed for normality using histograms. Descriptive analysis included 
mean and standard deviations, followed by multilevel linear regression analysis, accounting 
for the correlated nature of repeated measurements within individuals. Pearson’s correlation 
was used to assess correlation between relative change in RFCSA and diaphragm thickness at 
each time point during mechanical ventilation.  
Statistical analysis was completed using SPSS© Version 20 (SPSS, Inc. Chicago, Ill) and Stata 
Version 13.0. A p-value of ≤0.05 was considered statistically significant.   
RESULTS 
Participants 
Twenty-six patients were recruited between April and November 2014, of which 9 were 
categorised as Group 1, 7 as Group 2 and 10 as Group 3. Baseline characteristics for the 
patients according to group are reported in table 1. As expected inter-group analysis 
demonstrated significant variation in average partial pressure of carbon dioxide (p=0.000), 
with the hypercapnic group having significantly higher levels. The hypercapnic group also had 
significantly higher APACHE II scores (F=4.410; p=0.024, post hoc group 1 & 3 p=0.022), and 
lower numbers of organs failing on admission (H=15.030; p=0.001) when compared to both 
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the normocapnic (U=17.000; p=0.037) and acquired brain injury groups (U=4.000; p<0.001). 
All other inter-group baseline differences were non-significant.  
Table 1: Demographic Data for Each Group 
 Group 1 
ABI 
(n=9) 
Group 2 
Normocapnic 
(n=7) 
Group 3 
Hypercapnic 
(n=10) 
 
Male : Female 6 : 3 4 : 3 7 : 3 p = 0.861 
Age (years) 50.8 (18.1) 53.0 (29.5) 51.8 (16.7) p = 0.979 
BMI (kg/m2) 24.5 (2.8) 23.5 (3.4) 28.7 (7.7) p = 0.119 
APACHE II 9.4 (96.3 – 12.6) 11.7 (7.0 – 16.4) 15.4 (12.4 – 18.4) p = 0.024 
Number of organs 
failing in first 24 
hours (Based on 
SOFA Score) 
3 (3 - 4) 3 (2 – 3) 2 (1 – 3) p = 0.001 
Days of sedation 7 (7 – 14) 7 (6 – 12) 8 (5 – 7) p = 0.499 
Duration of 
mechanical 
ventilation (days) 
11 (8 – 14) 10 (7 – 22) 8 (5 – 15.75) p = 0.754 
Critical Care Length 
of Stay (level 3 & 2) 
(days) 
11 (8 – 16) 13 (11 – 24) 10 (7 – 19) p = 0.512 
Average PaCO2 
during study period 
(kPa) 
5.1 (0.4) 5.6 (0.4) 7.1 (0.8) p < 0.001 
BMI: Body Mass Index; APACHE II: Acute Physiology and Chronic Health Evaluation Version 
2; ABI: Acquired Brain Injury; SOFA: Sequential Organ Failure Assessment;  
Average PaCO2 calculated from admission to day 14 or extubation (whichever the sooner)  
Results reported as mean (SD) or Median (IQR) 
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Changes in diaphragm thickness 
Differences from baseline for the whole cohort (n=26) were: day 3 -0.44% (9.0) n=25; day 5 -
2.3% (7.9) n=22; day 7 -5.8% (9.5) n=17; and day 10 -6.5% (6.7) n=7 (see figure 1). Significant 
differences were observed between baseline to day 7 (p=0.029) and baseline to day 10 
(p<0.001). Inter-group comparisons for diaphragm thickness were non-significant at each 
time point (p=0.132) (see table 2). 
Figure 1: Percentage Change in Diaphragm Thickness from Baseline 
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Table 2: Percentage Change in Diaphragm Thickness from Baseline for Each Group 
 Group 1 
ABI 
Group 2 
Normocapnic 
Group 3 
Hypercapnic 
Day 3 % difference 
from baseline (sd) 
-2.1 (6.6) 
(n=9) 
0.5 (8.4) 
(n=7) 
0.5 (11.9) 
(n=9) 
Day 5 % difference 
from baseline (sd) 
-1.1 (6.5) 
(n=9) 
-4.3 (8.8) 
(n=6) 
-2.2 (9.6) 
(n=7) 
Day 7 % difference 
from baseline (sd) 
-2.8 (5.3) 
(n=7) 
-7.8 (4.8) 
(n=5) 
-8.0 (16.4) 
(n=5) 
Day 10 % difference 
from baseline (sd) 
-0.2 (2.9) 
(n=2) 
-11.6 (2.0) 
(n=4) 
1.46 (n/a) 
(n=1) 
ABI: Acquired Brain Injury 
 
Between group comparisons for diaphragm thickness were non-significant at each time 
point (p>0.05). 
 
Changes in RFCSA 
Change in RFCSA from baseline to Days 3, 5, 7, and 10 was calculated for all patients (figure 2). 
Day 3 mean change from baseline was -4.0% (3.3) n=25; day 5 -7.0% (4.1) n=22; day 7 -10.5% 
(5.4) n=17; and day 10 -14.9% (8.2) n=8. Significant differences (p<0.001) were observed for 
all comparisons from baseline (baseline to day 3, 5, 7, and 10). Inter-group analysis showed 
no significant differences between the groups (p=0.211) (table 3). 
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Figure 2: Percentage Change in RFCSA from Baseline 
 
Table 3: Percentage Change in RFCSA from Baseline for Each Group 
 Group 1 
ABI 
Group 2 
Normocapnic 
Group 3 
Hypercapnic 
Day 3 % difference 
from baseline (sd) 
-3.7 (4.0) 
(n=9) 
-4.9 (2.5) 
(n=7) 
-3.6 (3.2) 
(n=9) 
Day 5 % difference 
from baseline (sd) 
-5.9 (2.3) 
(n=9) 
-7.9 (4.3) 
(n=6) 
-7.6 (5.7) 
(n=7) 
Day 7 % difference 
from baseline (sd) 
-12.4 (4.9) 
(n=7) 
-7.2 (5.7) 
(n=5) 
-11.0 (5.3) 
(n=5) 
Day 10 % difference 
from baseline (sd) 
-15.2 (1.2) 
(n=2) 
-14.3 (8.2) 
(n=4) 
-15.9 (16.1) 
(n=2) 
ABI: Acquired Brain Injury 
 
Between group comparisons for diaphragm thickness were non-significant at each time point 
(p>0.05). 
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Relationship between change in diaphragm thickness and RF cross-sectional area 
The relationship between percentage change in diaphragm thickness and RFCSA at all time 
points was analysed using bivariate Pearson product-moment correlation coefficient and was 
not statistically significant (day 3: r=-0.161; day 5: r=-0.099; day 7: r=0.002; day 10: r=0.088). 
DISCUSSION 
This study demonstrated a significant decline in RFCSA from baseline to days 3, 5, 7 and 10 and 
in diaphragm thickness from baseline to days 7 and 10. There were no differences between 
the groups in either outcome measure, indicating that hypercapnia did not appear to 
influence respiratory and peripheral skeletal cross-sectional area in this small sample of 
people who were critically ill and receiving mechanical ventilation. 
 
Change in diaphragm muscle mass  
In the cohort of patients recruited, there was an average decrease of approximately 6% in 
diaphragm thickness by day 10 (from baseline). This decrease was significant at day 7 when 
compared to baseline (p=0.029).  
The observed reduction in diaphragmatic thickness was substantially less than that reported 
by both Grosu et al [16] (6% per day of mechanical ventilation) and Schepens et al [17] (26% 
change from baseline at 72 hours). However, recently Goligher et al [18] examined changes 
in diaphragmatic thickness in a large multicentre cohort of 107 mechanically ventilated and 
10 non-ventilated critically ill patients. In this cohort, there was a reduction of >10% thickness 
in 44% of patients, unchanged (<10%) in 44% of patients and increased (>10%) in 12% of 
patients. Similarly, Zambon et al [19] identified that rate of diaphragm thickness change was 
dependent on the mode of ventilation being delivered, with mandatory modes causing 7.5% 
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loss of thickness after 3 days, opposed to a 2.3% gain when only continuous positive pressure 
being utilised.  
The pattern of change in diaphragm thickness was inconsistent across the three groups. The 
percentage change from baseline to day 3 was greater in the ABI group than that in the other 
two groups, yet at days 5 and 7 the reverse was found. The relatively larger changes in the 
normocapnic and hypercapnic groups may account for the overall significant difference at day 
7. Similarly the larger number of people being ventilated at Day 10 in the normocapnic group 
may account for the overall significant difference at day 10. 
There are many potential causes for the differences in rate of diaphragm thinning within the 
current study and literature. The current study had a limited sample size especially when 
considering those assessed at day 10. Additionally, the data demonstrates large standard 
deviations suggesting a significant spread of results. Similarly, given the results of other 
studies [16], it may be hypothesised that weaning, ventilation mode or respiratory rate may 
be the major determinant or modifier of the rate of diaphragm thinning. As this was not 
controlled within the current study it is likely this may have had an effect especially when 
combined with the limited sample. 
Although not assessed in the current study, previous studies [19] have demonstrated altered 
rates of diaphragm thinning or diaphragm disfunction based on the mode of ventilation being 
utilised. When mandatory modes of ventilation, such as SIMV are utilised, the rate of atrophy 
is far greater (approximately 7.5%), with gradually reducing rates as ventilation support 
reduced. Indeed, continuous positive pressure ventilation resulted in an overall improvement 
in daily atrophy changes. It may also be argued that respiratory rate will also play a role, with 
higher rates of diaphragm activation may reduce likelihood of atrophy through a training 
effect.  
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Further study is still required to consolidate the understanding of the role of a variety of 
critical care interventions such as ventilator strategies and nutrition, and their potential 
effects on muscle physiology. This understanding is essential prior to universal 
implementation of hypercapnia or any other method in the prevention of ventilator induced 
diaphragmatic dysfunction. 
 
Change in quadriceps rectus femoris  
The current study has demonstrated significant reductions in RF cross-sectional area during 
the first 10 days of critical illness, with statistically significant differences at each time point. 
By day 10 of critical illness patients, on average, had lost over 14.9% of their RFCSA. The 
observed changes in rectus femoris compare favourably with previous research. At day 7 the 
current study demonstrated a 10.5% reduction from baseline. Similarly, Puthucheary et al [7] 
recorded a 10.3% reduction. Of note, Puthucheary et al. [7] concluded among these critically 
ill patients, muscle wasting occurred early and rapidly during the first week of critical illness. 
Other research has also shown significant reductions in RFCSA over time within critical care 
[5]. Furthermore, Gruther et al. [5], suggested that the rate of loss could be described using a 
logarithmic function which is independent of other variables e.g. age or pathology. These 
findings may provide insights into skeletal muscle wasting in critical illness. 
 
In keeping with diaphragm thickness, no between group differences were observed. 
However, Puthucheary et al. [7] also suggested that muscle wasting was more severe among 
those with multi-organ failure compared with single organ failure. Within the current study, 
the hypercapnic group had statistically higher APACHE II scores (when compared to ABI 
group), therefore based on Puthucheary et al [7], this group should have had the greatest rate 
of muscle mass loss. However, this did not occur, with the ABI group showing greater muscle 
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mass loss at day 7. These findings may in part be due to the small sample size and consequent 
variability in data, but could also be due to other factors such as hypercapnia. It may be 
possible to suggest that hypercapnia did indeed play a protective role by preventing high rates 
of muscle mass loss to a point of similarity with those with lower degrees of organ failure. 
Further investigation of this would require increased patient matching of numbers of organ 
failing and patient severity in an accurately powered study. 
 
Comparing diaphragm and rectus femoris 
No previous research has compared changes in muscle mass for both RFCSA and the diaphragm 
simultaneously, although Dres et al [20] observed that 63% of patients undergoing a 
spontaneous breathing trial had diaphragm dysfunction whilst 34% had limb muscle 
weakness, and 21% had both. Within a COPD population, Caron et al. [21] reported that 
several studies have highlighted important structural and biochemical modifications in limb 
and respiratory muscles, and hence they may respond differently to inactivity. 
 
In the current study, there was no observed relationship between the degree of change for 
the two muscles and hence peripheral skeletal and respiratory muscle may to be affected 
differently during critical illness. For RFCSA, all groups demonstrated a similar pattern of 
muscle mass change, and similar day 10 outcomes (all groups between 14 and 16% reduction 
in RFCSA). In contrast, day 10 diaphragm thickness varied greatly between groups (all groups 
between 1.5% increase and 12% decrease). This supports the theory that skeletal and 
respiratory muscles respond differently and may be influenced by varied factors [16]. As 
previously identified, diaphragm thickness change may be influenced by ventilation modes 
and weaning strategies such as assisted spontaneous breathing. Use of such modes will result 
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in increased diaphragm activity as required to initiate inspiration and hence potentially 
encourage diaphragm thickening, whereas they will have no influence on quadriceps activity. 
Changes in quadriceps activity relies more on voluntary muscle contraction which is unlikely 
in the initial stages of critical illness whilst the patient remains sedated. This may be 
particularly apparent in the traumatic brain injury group which are likely to have required 
longer periods of sedation and an inability to produced voluntary quadriceps activity as a 
result of their neurological injury. 
 
Limitations 
This study aimed to recruit a total of 30 patients (10 in each group) to understand the effects 
of hypercapnia on change in diaphragm and peripheral skeletal muscle during critical illness. 
A limited time-frame for recruitment meant the target recruitment was not met and hence 
the robustness and generalisability of the findings is reduced. Nonetheless these data could 
be used to power sample sizes in future research.  
In the current study, baseline measurements were completed within 24 hours of admission 
to critical care. However, day of ICU admission may not accurately reflect the onset of critical 
illness [6].  Muscle loss may occur prior to ICU admission, albeit this is challenging to account 
for.  Populations such as those patients admitted with trauma may represent the closest 
reflection of an acute, sudden insult where pre-admission muscle decline may not develop. 
This is an area for further consideration and research. 
 
A single author (PT) was responsible for all ultrasound imaging throughout the study, albeit 
was not blinded to patient group allocation.   The same author additionally analysed all 
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ultrasound images. Due to the pilot nature of the study the intra-observer reliability of the 
measurements was not analysed. Additionally, a standardised operating protocol was 
adopted for testing of both diaphragm and RFCSA, including patient position, anatomical 
marking and the ultrasound scan procedure. However, absolute values of end-expiratory 
pressure were not measured. Variability in end-expiratory pressure (as a result of both 
internal and external PEEP) may have altered functional residual capacity and hence altered 
the resting position of the diaphragm [21]. Similarly differences in body somatotype and the 
presence of high intra-abdominal pressures may have affected diaphragm ultrasound 
thickness especially considering the limited sample size. 
 
CONCLUSION 
In this pilot study, hypercapnia had no influence on total loss of diaphragm thickness and 
RFCSA. Although further research is required correcting for influence of organ failure, severity 
of illness and ventilation mode. A significant reduction in muscle mass in rectus femoris cross 
sectional area was observed at all time points and significant reductions in diaphragm 
thickness at day 7. There was no correlation between the loss of diaphragm thickness and 
RFCSA.  
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AB I – Acquired brain injury 
ASIS – Anterior superior iliac spine 
ICU – Intensive care unit 
COPD – Chronic obstructive pulmonary disease  
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